Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
December 27, 2023
Novocure to Participate in 42nd Annual J.P. Morgan Healthcare Conference
November 28, 2023
Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability
November 21, 2023
Novocure to Participate in 35th Annual Piper Sandler Healthcare Conference
November 10, 2023
Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting
October 26, 2023
Novocure Reports Third Quarter 2023 Financial Results
October 15, 2023
Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023
October 12, 2023
Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program
October 2, 2023
Novocure to Report Third Quarter 2023 Financial Results
September 29, 2023
Novocure Announces Presence at American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting
September 8, 2023
Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer
August 29, 2023
Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
August 28, 2023
Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian Cancer
August 25, 2023
Novocure to Participate in Upcoming Investor Conferences
July 27, 2023
Novocure Reports Second Quarter 2023 Financial Results
July 21, 2023
Novocure Announces Favorable Independent Data Monitoring Committee Recommendation to Continue Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy in Pancreatic Cancer
July 3, 2023
Novocure to Report Second Quarter 2023 Financial Results
June 6, 2023
LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
June 1, 2023
Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education
May 4, 2023
Novocure Reports First Quarter 2023 Financial Results
April 26, 2023
Novocure Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
April 14, 2023
Novocure Announces 27 Presentations, Including Real-World Evidence and Preclinical Research, at American Association for Cancer Research (AACR) Annual Meeting 2023
April 3, 2023
Novocure to Report First Quarter 2023 Financial Results
March 29, 2023
Kristin Stafford Joins Novocure Board of Directors
March 16, 2023
Novocure Announces 5th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
March 1, 2023
Novocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France
March 1, 2023
Novocure Announces Last Patient Enrolled in Pivotal METIS Study of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer
February 23, 2023
Allyson J. Ocean, M.D., Joins Novocure Board of Directors
February 23, 2023
Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
February 15, 2023
Novocure Announces Last Patient Enrolled in Pivotal PANOVA-3 Study of Tumor Treating Fields in Pancreatic Cancer
January 19, 2023
Novocure Announces Organizational Changes to Prepare for Future Growth
January 9, 2023
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update
January 5, 2023
Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint